Lotus Pharmaceuticals Valuation
| LTUS Stock | USD 0.01 0 28.57% |
Lotus Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Lotus Pharmaceuticals from analyzing the firm fundamentals such as Profit Margin of 0.02 %, return on equity of 0.0182, and Current Valuation of 762.17 K as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend acquiring undervalued stocks and selling overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Lotus Pharmaceuticals' price fluctuation is out of control at this time. Calculation of the real value of Lotus Pharmaceuticals is based on 3 months time horizon. Increasing Lotus Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Lotus Pharmaceuticals is useful when determining the fair value of the Lotus pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Lotus Pharmaceuticals. Since Lotus Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lotus Pink Sheet. However, Lotus Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.005 | Real 0.004636 | Hype 0.006077 |
The real value of Lotus Pink Sheet, also known as its intrinsic value, is the underlying worth of Lotus Pharmaceuticals Company, which is reflected in its stock price. It is based on Lotus Pharmaceuticals' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Lotus Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Lotus Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Lotus Pharmaceuticals helps investors to forecast how Lotus pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lotus Pharmaceuticals more accurately as focusing exclusively on Lotus Pharmaceuticals' fundamentals will not take into account other important factors: Lotus Pharmaceuticals Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Lotus Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Lotus Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lotus Pharmaceuticals competition to find correlations between indicators driving Lotus Pharmaceuticals's intrinsic value. More Info.Lotus Pharmaceuticals is currently regarded as number one stock in price to earning category among related companies. It is rated below average in price to book category among related companies fabricating about 0.04 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Lotus Pharmaceuticals is roughly 23.68 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Lotus Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Lotus Pharmaceuticals' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lotus Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Lotus Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Lotus Pharmaceuticals and how it compares across the competition.
About Lotus Pharmaceuticals Valuation
The pink sheet valuation mechanism determines the current worth of Lotus Pharmaceuticals on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Lotus Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Lotus Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Lotus Pharmaceuticals's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Lotus Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lotus Pharmaceuticals. We calculate exposure to Lotus Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lotus Pharmaceuticals's related companies.Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the Peoples Republic of China. Lotus Pharmaceutical operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 233 people.
8 Steps to conduct Lotus Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Lotus Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Lotus Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Lotus Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Lotus Pharmaceuticals' revenue streams: Identify Lotus Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Lotus Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Lotus Pharmaceuticals' growth potential: Evaluate Lotus Pharmaceuticals' management, business model, and growth potential.
- Determine Lotus Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Lotus Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Lotus Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Lotus Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Quarterly Earnings Growth Y O Y | -0.822 | |
| Retained Earnings | 60.2 M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lotus Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Lotus Pink Sheet analysis
When running Lotus Pharmaceuticals' price analysis, check to measure Lotus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceuticals is operating at the current time. Most of Lotus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lotus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |